Introduction
pluripotency, self-renewal and differentiation of stem cells [6, 7, 9] . Multipotent adult progenitor cells (MAPCs) are isolated from postnatal human and rodent tissues including bone marrow, muscle and brain [10] . These cells have been well characterized and are able to differentiate into a variety of cell lineages of mesodermal, ectodermal and endodermal origins in vitro and in vivo including vascular endothelium, hepatocytes and neurons [11] . Similar to ESCs, MAPCs exhibit remarkable self-renewal capability and express Oct-4 abundantly [12, 13] . Recently, we demonstrated that nitric oxide enhanced Oct-4 expression and promoted endothelial differentiation of mouse MAPCs in vitro [14] .
The outcomes of ox-LDL on its target cells are variable and complex depending on individual cell type. Ox-LDL inhibits proliferation and promotes apoptosis of vascular endothelial cells (ECs)
and EPCs [15, 34] ; whereas it induces cell proliferation of vascular smooth muscle cells, and attenuates apoptosis of macrophages and monocytes through activation of mitogen-activated protein kinase [16] [17] [18] 
. Ox-LDL interferes with the function of EPCs through multiple mechanisms including inhibition of endothelial nitric oxide synthase (eNOS), downregulation of E-selectin and integrin alpha(v)beta(5) expression, inactivation of telomerase and acceleration of cell senescence (33, 34, 41). The present study was designed to investigate the effect of ox-LDL on the behaviour of rat MAPCs including Oct-4 expression, self-renewal and their endothelial differentiation and the underlying mechanisms.

Materials and methods
LDL isolation and oxidative modification
Plasma from healthy volunteers was obtained from Hong Kong Red Cross (Kowloon, Hong Kong) . LDL was prepared from plasma with the method as described [19] . Ox-LDL was prepared by exposure of LDL to CuSO4 in dark for 24 hrs; and the degree of LDL oxidation was monitored by measuring the production of thiobarbituric acid reactive substances (TBARS) as described [20] . The value for TBARS in ox-LDL was determined to be 30. 8 
Cell culture
Rat MAPCs were isolated and cultured with the method as described [21] 
Endothelial differentiation
Endothelial differentiation of MAPCs was initiated with the method as described [13, 22] . 
Quantitative real-time PCR
Total RNA was extracted from MAPCs treated with ox-LDL or native LDL using RNeasy kit (Qiagen). Real-time PCR was performed as described [14] . mRNA levels were normalized by using GAPDH as housekeeping gene and compared to the mRNA levels in rat spleen. The detailed primer sequences for vWF, Oct-4, CD31, Flk-1 and GAPDH were published previously [13] . 
Immunofluorescence staining for vWF
In vitro tube formation assay
In vitro vascular tube formation from MAPCs-derived cells was evaluated in three-dimensional growth factor-reduced Matrigel (10 mg/ml; Collaborative Research, Bedford, MA) as described [14, 22] .
Cell transfection with Akt plasmid
MAPCs were transfected with Myristoylated (Myr)-Akt plasmid using the Nucleofector kit (VPE-1001) (Amaxa Biosystems, Gaithersburg, MD) as described [23, 24] . 
Western blot analysis
Cells were collected and prepared as described for Western blot analysis [14, 22] 
n ϭ 4). Of note, Oct-4 expression in MAPCs was not affected by native LDL (data not shown).
Ox-LDL inhibited self-renewal of MAPCs
Under normal condition, MAPCs doubling time was 12.4 hrs. It was dramatically increased dose-dependently up to 34.2 hrs (P Ͻ 0.05, n ϭ 4) by ox-LDL (Fig. 2A). Accordingly, the MAPC population in culture was dramatically decreased by ox-LDL in a dose-and time-dependent manner (Fig. 2B). When ox-LDL concentration was increased to 40 g/ml, the cell number was reduced to less than 30% of control (P Ͻ 0.001, n ϭ 4). Experiments were then performed to determine the mechanisms for the reduced cell number by ox-LDL. Ox-LDL significantly inhibited the proliferation of MAPCs in a concentrationand time-dependent manner (Fig. 2C). The inhibitory effect was most prominent at 24 hrs of incubation with 40 g/ml ox-LDL (P Ͻ 0.001, n ϭ 4). Of note, native LDL had no effect on the number and proliferation of MAPCs (data not shown). There was a low level of apoptosis in MAPCs cultured in normal condition (Fig. 2D). Cell apoptosis was significantly increased dose-dependently by up to 3.5-fold when MAPCs exposed to ox-LDL (from 0 to 40 g/ml) for 24 hrs (P Ͻ 0.01, n ϭ 4). When ox-LDL concentration was increased to 80 g/ml, cell death occurred to over 90% of MAPCs as evaluated by Trypan blue exclusion assay (data not shown). In
Fig. 1 Ox-LDL inhibited Oct-4 expression. When MAPCs were exposed to ox-LDL (from 0 to 40 g/ml) for 24 hrs, Oct-4 expression was significantly decreased with a concentration-dependent reduction of both mRNA and protein levels in the cells. Oct-4 expression was not affected by native LDL (data not shown). **P Ͻ 0.01 versus 0 g/ml (n ϭ 4). (A) Ox-LDL dose-dependently inhibited Oct-4 transcriptional expression in MAPCs with decreased mRNA level as measured by RT-PCR. (B) Oct-4 protein content was dramatically decreased dose-dependently by ox-LDL in MAPCs after 24 hrs of incubation as determined by Western blot. addition, the expression of proapoptotic protein Bax was significantly up-regulated by up to 3.0-fold in MAPCs incubated with ox-LDL for 24 hrs dose-dependently (from 0 to 40 g/ml) as determined by Western blot (P Ͻ 0.01, n ϭ 4; Fig. 2E). These data indicated that ox-LDL reduced MAPC population via a combination of decreased cell proliferation and enhanced cell apoptosis.
Ox-LDL attenuated endothelial differentiation of MAPCs
As expected, the differentiating MAPCs started to express endothelial markers vWF, CD31 and Flk-1 by day 7 of differentiation (Fig. 3) (Fig. 4) . Akt phosphorylation was significantly decreased dose-dependently by up to 97.6% (n ϭ 4, P Ͻ 0.01) in MAPCs when incubated with ox-LDL for 24 hrs (Fig. 4A) . No change in ERK1/2 phosphorylation by ox-LDL was observed in MAPCs (Fig. 4B) (Fig. 6A-C) . With Akt overexpression, the cell population was only decreased by 7.3 Ϯ 4.6% (n ϭ 4, P Ͼ 0.05) by 40 ug/ml ox-LDL; whereas the cell number in control group (transfected with empty vector) was decreased by 50.7 Ϯ 2.8% (n ϭ 4, P Ͻ 0.01) (Fig. 6A) . Similar results were obtained for cell proliferation and apoptosis in MAPCs that overexpressed active Akt (Fig. 6B and C) . Surprisingly, the inhibitory effect of ox-LDL on Oct-4 transcriptional expression (mRNA) was completely reversed in MAPCs transfected with Myr-Akt (Fig. 6D) ; whereas Oct-4 protein level was only partially recovered (Fig. 6E) (Fig. 6E) . Fig. 6F and G) . [7, 9, 25] . However, the regulatory mechanisms for Oct-4 expression are poorly understood. A number of factors are involved in Oct-4 expression including leukemia inhibitory factor (LIF), serum and retinoic acid [26] . LIF and serum are required for Oct-4 expression in mouse ESCs; whereas retinoic acid suppresses Oct-4 expression. Oct-4 is also expressed abundantly in rat MAPCs [13, 21] . [16] [17] [18] [30] [31] [32] [4, 15] . In this study, ox-LDL inhibited cell proliferation, induced apoptosis of MAPCs, and caused cell necrosis at high concentration (80 g/ml), as well as suppressed endothelial differentiation of MAPCs. The EPC number and function are known to be reduced in hyperlipidemic patients. Ox-LDL inhibits EPC proliferation and differentiation, and suppress their function and survival [4, 5, 33, 34] 
of differentiation. (E) CD31 expression in the differentiating cells was dramatically reduced by ox-LDL as analysed by Western blot at week 2 of differentiation.
Akt overexpression reversed the effect of ox-LDL on MAPCs
To investigate the role of Akt signalling in mediating the effect of ox-LDL on MAPCs, the cells were transfected with a constitutively active Akt (Myr-Akt). After 24 hrs of transfection, over 60% MAPCs were successfully transfected with Akt plasmids as determined by fluorescence microscopy and cytometry (Fig. 5). The transfected cells exhibited a dramatic increase of over 30-time in phosphorylated Akt over control (n ϭ 4, P Ͻ 0.001). Interestingly, Akt overexpression had no effect on cell proliferation, apoptosis and Oct-4 expression in MAPCs under normal conditions (Fig. 6), suggesting that baseline Akt signalling was adequate to maintain their normal function. However, decreased cell proliferation and enhanced apoptosis by ox-LDL were completely prevented in MAPCs overexpressing active Akt
Akt overexpression also completely restored the potential of MAPCs to differentiate into functioning ECs impaired by ox-LDL as reflected by normalization of diminished expression of endothelial marker vWF and in vitro vascular structure formation (
Discussion
In this study, we reported that ox-LDL significantly downregulated Oct-4 expression in
Fig. 4 Effect of ox-LDL on Akt and ERK1/2 phosphorylation in MAPCs. When MAPCs were incubated with ox-LDL (from 0 to 40 g/ml) for 24 hrs, Akt phosphorylation was dramatically inhibited in the cells (A) in a dosedependent manner; although ERK1/2 activation was not affected (B). Native LDL had no effect on Akt or ERK1/2 phosphorylation (data not shown
This was confirmed in the present study at both protein and transcriptional levels. Oct-4 expression was significantly decreased by ox-LDL in MAPCs, suggesting that ox-LDL could modify the behaviour of bone marrow stem cells. One of the important features for stem cells is self-renewal, a process that the cells divide to produce two identical daughter cells. Oct-4 is important in stem cell self-renewal through a complex and sophisticated transcriptional network of genes and growth factors [27-29]. As ox-LDL decreases Oct-4 expression in MAPCs, it may impair their capability of self-renewal. Indeed, the number of MAPCs was dramatically decreased with significant increase in their doubling time when exposed to ox-LDL, indicating that self-renewal of MAPCs was suppressed by ox-LDL. Ox-LDL-induced decrease in cell population was a combination of decreased proliferation and increased apoptosis of MAPCs. Increased apoptosis by ox-LDL was further supported by enhanced expression of proapoptotic protein Bax in ox-LDLtreated cells. The effect of ox-LDL on its target cells is very variable, depending on the cell type. Ox-LDL promotes proliferation of macrophages and vascular smooth muscle cells, and inhibits apoptosis of macrophages and monocytes through MAPK activation
. On the other hand, ox-LDL inhibits proliferation and promotes apoptosis of vascular ECs and EPCs
